Literature DB >> 24470255

Loss of Cbl-PI3K interaction enhances osteoclast survival due to p21-Ras mediated PI3K activation independent of Cbl-b.

Naga Suresh Adapala1, Mary F Barbe, Alexander Y Tsygankov, Joseph A Lorenzo, Archana Sanjay.   

Abstract

Cbl family proteins, Cbl and Cbl-b, are E3 ubiquitin ligases and adaptor proteins, which play important roles in bone-resorbing osteoclasts. Loss of Cbl in mice decreases osteoclast migration, resulting in delayed bone development where as absence of Cbl-b decreases bone volume due to hyper-resorptive osteoclasts. A major structural difference between Cbl and Cbl-b is tyrosine 737 (in YEAM motif) only on Cbl, which upon phosphorylation interacts with the p85 subunit of phosphatidylinositol-3 Kinase (PI3K). In contrast to Cbl(-/-) and Cbl-b(-/-) , mice lacking Cbl-PI3K interaction due to a Y737F (tyrosine to phenylalanine, YF) mutation showed enhanced osteoclast survival, but defective bone resorption. To investigate whether Cbl-PI3K interaction contributes to distinct roles of Cbl and Cbl-b in osteoclasts, mice bearing CblY737F mutation in the Cbl-b(-/-) background (YF/YF;Cbl-b(-/-) ) were generated. The differentiation and survival were augmented similarly in YF/YF and YF/YF;Cbl-b(-/-) osteoclasts, associated with enhanced PI3K signaling suggesting an exclusive role of Cbl-PI3K interaction, independent of Cbl-b. In addition to PI3K, the small GTPase Ras also regulates osteoclast survival. In the absence of Cbl-PI3K interaction, increased Ras GTPase activity and Ras-PI3K binding were observed and inhibition of Ras activation attenuated PI3K mediated osteoclast survival. In contrast to differentiation and survival, increased osteoclast activity observed in Cbl-b(-/-) mice persisted even after introduction of the resorption-defective YF mutation in YF/YF;Cbl-b(-/-) mice. Hence, Cbl and Cbl-b play mutually exclusive roles in osteoclasts. Whereas Cbl-PI3K interaction regulates differentiation and survival, bone resorption is predominantly regulated by Cbl-b in osteoclasts.
© 2014 Wiley Periodicals, Inc.

Entities:  

Keywords:  AKT; Cbl-b; GSK; RANKL; SURVIVAL

Mesh:

Substances:

Year:  2014        PMID: 24470255      PMCID: PMC4634568          DOI: 10.1002/jcb.24779

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  43 in total

Review 1.  Cbl-phosphatidylinositol 3 kinase interaction differentially regulates macrophage colony-stimulating factor-mediated osteoclast survival and cytoskeletal reorganization.

Authors:  Naga Suresh Adapala; Mary F Barbe; Wallace Y Langdon; Alexander Y Tsygankov; Archana Sanjay
Journal:  Ann N Y Acad Sci       Date:  2010-03       Impact factor: 5.691

2.  The p85alpha subunit of class IA phosphatidylinositol 3-kinase regulates the expression of multiple genes involved in osteoclast maturation and migration.

Authors:  Veerendra Munugalavadla; Sasidhar Vemula; Emily Catherine Sims; Subha Krishnan; Shi Chen; Jincheng Yan; Huijie Li; Paul J Niziolek; Clifford Takemoto; Alexander G Robling; Feng-Chun Yang; Reuben Kapur
Journal:  Mol Cell Biol       Date:  2008-09-22       Impact factor: 4.272

3.  TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.

Authors:  Qisheng Peng; Shikha Malhotra; James A Torchia; William G Kerr; K Mark Coggeshall; Mary Beth Humphrey
Journal:  Sci Signal       Date:  2010-05-18       Impact factor: 8.192

4.  Hyperactivation of p21ras and PI3K cooperate to alter murine and human neurofibromatosis type 1-haploinsufficient osteoclast functions.

Authors:  Feng-Chun Yang; Shi Chen; Alexander G Robling; Xijie Yu; Todd D Nebesio; Jincheng Yan; Trent Morgan; Xiaohong Li; Jin Yuan; Janet Hock; David A Ingram; D Wade Clapp
Journal:  J Clin Invest       Date:  2006-10-19       Impact factor: 14.808

Review 5.  c-Cbl and Cbl-b ubiquitin ligases: substrate diversity and the negative regulation of signalling responses.

Authors:  Christine B F Thien; Wallace Y Langdon
Journal:  Biochem J       Date:  2005-10-15       Impact factor: 3.857

6.  Genetic ablation of the c-Cbl ubiquitin ligase domain results in increased energy expenditure and improved insulin action.

Authors:  Juan C Molero; Nigel Turner; Christine B F Thien; Wallace Y Langdon; David E James; Gregory J Cooney
Journal:  Diabetes       Date:  2006-12       Impact factor: 9.461

7.  Down-regulation of ubiquitin ligase Cbl induced by twist haploinsufficiency in Saethre-Chotzen syndrome results in increased PI3K/Akt signaling and osteoblast proliferation.

Authors:  Hind Guenou; Karim Kaabeche; Cécilie Dufour; Hichem Miraoui; Pierre J Marie
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

Review 8.  The role(s) of Src kinase and Cbl proteins in the regulation of osteoclast differentiation and function.

Authors:  William C Horne; Archana Sanjay; Angela Bruzzaniti; Roland Baron
Journal:  Immunol Rev       Date:  2005-12       Impact factor: 12.988

9.  Pathway crosstalk between Ras/Raf and PI3K in promotion of M-CSF-induced MEK/ERK-mediated osteoclast survival.

Authors:  Elizabeth W Bradley; Ming M Ruan; Anne Vrable; Merry Jo Oursler
Journal:  J Cell Biochem       Date:  2008-07-01       Impact factor: 4.429

10.  Loss of Cbl-b increases osteoclast bone-resorbing activity and induces osteopenia.

Authors:  Arata Nakajima; Archana Sanjay; Riccardo Chiusaroli; Naga Suresh Adapala; Lynn Neff; Cecile Itzsteink; William C Horne; Roland Baron
Journal:  J Bone Miner Res       Date:  2009-07       Impact factor: 6.741

View more
  13 in total

1.  Cbl-PI3K interaction regulates Cathepsin K secretion in osteoclasts.

Authors:  Jungeun Yu; Naga Suresh Adapala; Laura Doherty; Archana Sanjay
Journal:  Bone       Date:  2019-07-09       Impact factor: 4.398

2.  Loss of Cbl-PI3K interaction modulates the periosteal response to fracture by enhancing osteogenic commitment and differentiation.

Authors:  Vanessa Scanlon; Bhavita Walia; Jungeun Yu; Marc Hansen; Hicham Drissi; Peter Maye; Archana Sanjay
Journal:  Bone       Date:  2016-11-22       Impact factor: 4.398

3.  The Hajdu Cheney Mutation Is a Determinant of B-Cell Allocation of the Splenic Marginal Zone.

Authors:  Jungeun Yu; Stefano Zanotti; Bhavita Walia; Evan Jellison; Archana Sanjay; Ernesto Canalis
Journal:  Am J Pathol       Date:  2017-10-14       Impact factor: 4.307

4.  miR-216a rescues dexamethasone suppression of osteogenesis, promotes osteoblast differentiation and enhances bone formation, by regulating c-Cbl-mediated PI3K/AKT pathway.

Authors:  H Li; T Li; J Fan; T Li; L Fan; S Wang; X Weng; Q Han; R C Zhao
Journal:  Cell Death Differ       Date:  2015-07-24       Impact factor: 15.828

5.  Exploring the relationship between osteoporosis and polycystic ovary syndrome based on bioinformatics.

Authors:  Chun-Xiao Dang; Ding Wang; Xiao Yu; Peng-Fei Liu; Jin-Xing Liu
Journal:  Medicine (Baltimore)       Date:  2022-06-24       Impact factor: 1.817

Review 6.  Development of degradable magnesium-based metal implants and their function in promoting bone metabolism (A review).

Authors:  Zhengming Shan; Xinhui Xie; Xiaotao Wu; Suyang Zhuang; Cong Zhang
Journal:  J Orthop Translat       Date:  2022-10-08       Impact factor: 4.889

7.  Loss of Cbl-PI3K interaction in mice prevents significant bone loss following ovariectomy.

Authors:  Naga Suresh Adapala; Danielle Holland; Vanessa Scanlon; Mary F Barbe; Wallace Y Langdon; Alexander Y Tsygankov; Joseph A Lorenzo; Archana Sanjay
Journal:  Bone       Date:  2014-07-01       Impact factor: 4.398

Review 8.  E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy.

Authors:  D Jafari; M J Mousavi; S Keshavarz Shahbaz; L Jafarzadeh; S Tahmasebi; J Spoor; A Esmaeilzadeh
Journal:  Clin Exp Immunol       Date:  2021-01-10       Impact factor: 5.732

Review 9.  Modulation of Immune Cell Functions by the E3 Ligase Cbl-b.

Authors:  Christina Lutz-Nicoladoni; Dominik Wolf; Sieghart Sopper
Journal:  Front Oncol       Date:  2015-03-11       Impact factor: 6.244

10.  Role of Cbl-PI3K Interaction during Skeletal Remodeling in a Murine Model of Bone Repair.

Authors:  Vanessa Scanlon; Do Yu Soung; Naga Suresh Adapala; Elise Morgan; Marc F Hansen; Hicham Drissi; Archana Sanjay
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.